Citace podle APA

Tfayli, H., Ulnach, J. W., Lee, S., Sutton-Tyrrell, K., & Arslanian, S. (2011). Drospirenone/Ethinyl Estradiol Versus Rosiglitazone Treatment in Overweight Adolescents with Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors. Endocrine Society.

Styl Chicago

Tfayli, Hala, Julia Warren Ulnach, SoJung Lee, Kim Sutton-Tyrrell, a Silva Arslanian. Drospirenone/Ethinyl Estradiol Versus Rosiglitazone Treatment in Overweight Adolescents With Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors. Endocrine Society, 2011.

Citace podle MLA

Tfayli, Hala, et al. Drospirenone/Ethinyl Estradiol Versus Rosiglitazone Treatment in Overweight Adolescents With Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors. Endocrine Society, 2011.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..